Molecular Diagnostics

Elevated Mir-24-3p Plays Prognostic Role in Breast Cancer
Breast cancer is the most common malignancy in women. In 2018 an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the USA, along with 63,960 new cases of non-invasive breast cancer. Therefore, there is a need to identify novel prognostic and predictive markers of occult metastases to better individualize adjuvant systemic therapy. More...12 Mar 2018

Sensitive ELISA Detects ZIKV Infection before Onset of Symptoms
A latest generation immunoassay for Zika virus (ZIKV) infection should help in guiding clinical management of mothers at risk for potential exposure to ZIKV and enable insights into the epidemiology of ZIKV infections. More...12 Mar 2018


Microfluidic Device Brings Single-Cell Technology to Bedside
The complex architecture and associated higher-order function of human tissues relies on functionally and molecularly diverse cell populations. Defining the cellular subsets found in pathologic tissues provides insights into disease etiology and treatment options. More...06 Mar 2018



Multigene Breast Cancer Recurrence Signatures Tests Compared
A comparison of commercially available multigene breast cancer recurrence signatures suggests that some tests may be better than others at assessing which patients are at risk for late distant recurrence, which could be impacting oncologists' ability to guide appropriate treatment decisions for patients. More...03 Mar 2018
In Other News
Colorectal Cancer Clues Provided by Polyp Profiles
Ovarian Cancer Risk May Be Paternally Inherited
Kidney Biopsy Profiles Predict Delayed Graft Function
Novel Saliva-Based PCR Assay Detects HIV Antibodies Earlier
Tests Links Circulating Tumor DNA and Breast Cancer Survival
Blood Test Designed for Multiple Tick-borne Diseases
Multiple Myeloma Risk Genes Revealed
Next-Gen Sequencing of CSF Diagnoses Neurobrucellosis
Molecular Test Adapted for Parkinson’s and DLB
Genomic Sequencing Augments Diagnosis of Lymphoid Cancer
Epigenetic Signatures Show Promise for Diagnosing Neurodevelopmental Disorders
Esophageal Cancer GWAS Leads to Risk Variants
Molecular Test Device Developed for RNA Viral Detection
HPV Found Hidden on Surface of Tonsils
Colorectal Cancer Immunohistochemistry Panel Launched
Bacteria Play Critical Role in Driving Colon Cancers
Residual Disease in Leukemia Patients Identified by ddPCR
Genetic Biomarkers Determine Risk of Developing Endometriosis
Analysis Offers Treatment Options for Olfactory Neuroblastoma
Mutation Found in Families with Contradictory Blood Sugars
Genetic Mutation Linked to Crohn's and Parkinson's Diseases
Immune Response Tests Enable Rapid Antibiotic Decisions
Lab-Developed Tests Compared with Approved Diagnostics
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.